Amino Collective

Luma Group is passionately leading a transformation in healthcare, driven by a deep-seated commitment to enhance human health. We’re on a mission to turn visionary science into revolutionary healthcare solutions. Our team unites a dynamic mix of investors, scientists, clinicians, and entrepreneurs, all dedicated to advancing human health outcomes. We are not just funding remarkable scientific discoveries; we are investing in the future of humanity. Our focus is on nurturing groundbreaking innovations leveraging advanced computation and artificial intelligence that promise to redefine healthcare, ensuring that every investment we make contributes to a healthier, brighter future for all. Our approach is hands-on and collaborative, partnering with the brightest minds in science, clinical research, engineering, and entrepreneurship. We’re not just investors; we’re co-creators, working side-by-side with innovators and dreamers to transform cutting-edge scientific discoveries into groundbreaking therapeutics, diagnostics, and medical devices. Our goal is clear: to make a significant and lasting impact on human health. Every project we embark on is a step towards redefining what’s possible in healthcare, ensuring that we’re not just part of the conversation, but leading the charge in creating a healthier future for everyone.

We invest in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. We are curious, rigorous, collaborative, and passionate about our work; we are also long-term investors in our team.

Harmonix invests in technological breakthroughs that will help create a future for a healthy, operational, and peaceful civilization. The fund focuses on exceptional entrepreneurs and innovative healthcare, life sciences, and deep tech companies. Harmonix is a multi-disciplinary team comprising scientists, researchers, operators, entrepreneurs, and industry experts with over 70 years of cumulative experience. Our diverse team provides founders with deep technical, operating, industry, and advisory expertise to accelerate and commercialize the next generation of technological advances. Harmonix accelerates scientific discoveries to advance human health and technology. We invest in companies that have functional solutions to real world problems. The Harmonix Process We deploy an evidence-based due diligence framework in assessing companies. Research: We identify opportunities ripe for innovation and examine areas where current standards of R&D, care, treatment, or workflow processes are inadequate. We find companies with functional solutions to problems that can create real value for stakeholders. Invest: We assess not only the technical dimensions of a venture, including supporting proof-of-concept data but also founder-fund fit. Our team looks for founders with emotional intelligence and demonstrated capacity for leadership and integrity. Accelerate: We support founders in all realms of the entrepreneurial process, including technical, operational, and business development support. We offer access to advisors who provide a level of expertise that is unavailable to many early-stage scientific companies.

We are in the age of discovery, seizing a unique moment in time. Every generation experiences a breakthrough that alters the world. Technology has transformed virtually every aspect of our lives, and now it’s healthcare’s turn. aMoon is here to accelerate this transformation. We partner with exceptional entrepreneurs who harness groundbreaking science and technology to transform healthcare. Through aMoon Velocity and aMoon Growth, we invest in early and late-stage companies pursuing disruptive, cutting-edge solutions for high unmet medical needs. We build bridges between our portfolio companies and global tech, finance and medical research hubs to enable entrepreneurs to turn their vision into reality.

Biospring Partners was founded in 2020 to invest in companies with the potential to fundamentally shift how technology is utilized across the life sciences sector. Michelle Dipp and Jennifer Lum came together to combine their experience in healthcare, technology, investing and operations to offer a differentiated approach to growth equity. Expanding the potential of life sciences technology We focus on identifying long-term themes within life sciences technology. We build trusted partnerships with management teams to support the growth of their businesses. Sectors we invest in Biospring invests in growth-stage B2B companies that are driving innovation across the life sciences industry and beyond. Our Approach We are a trusted partner that thrives in building long term strategic partnerships. We work closely alongside our companies to broaden their ambition and strengthen their path to growth. Our Investment Criteria$10M+ in annual revenue 30%+ revenue growth Diverse customer base

Asabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. Impact: We want to push the boundaries of science and medicine improving patient’s life Disruptive: We look for highly innovative and transformative technologies Hands-on: We consider ourselves partners and collaborators to our portfolio companies